« Return to News | CROs/Service Providers

Medpace Acquires European CRO, Has Big Plans for Growth

Thursday, January 21, 2010 06:04 PM

Cincinnati-based contract research organization (CRO) Medpace acquired European CRO Medical Consulting Dr. Schlichtiger for an undisclosed sum.

Based in Munich, Germany, Medical Consulting provides drug development services with a focus on regulatory consulting and pharmacovigilance. The company was founded in 1989 by Ursula Schlichtiger, M.D., now the company’s general manager.

Schlichtiger will join the Medpace team as managing director and senior director of medical and regulatory affairs.

Medpace plans to complete the integration of Medical Consulting later this year.

According to Medpace, the acquisition will strengthen the CRO’s European presence by providing centralized European hubs for regulatory submissions and approvals as well as drug safety management and reporting.

Medpace’s European headquarters is based in The Netherlands with regional offices scattered through Europe. The CRO also has Asian headquarters in Singapore and regional offices in Asia, Australia, South Africa and the Americas.

U.S. investigative sites rated Medpace the top CRO to work with in the 2009 CenterWatch Site Survey. The company has 1000 employees worldwide but plans to add another 760 by 2014. To accommodate this growth, Medpace began construction earlier this month on a new 132,000-square-foot corporate headquarters  in Cincinnati.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.